Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision v3.4.2 to the history and removed the earlier v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the history.SummaryDifference0.0%

- Check41 days agoChange DetectedFooter now shows Revision: v3.3.4, replacing v3.3.3, reflecting the latest site revision.SummaryDifference0.0%

- Check63 days agoChange DetectedA new history entry Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link along with the previous Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page history shows a revision bump from v3.2.0 to v3.3.2, a metadata update with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedDeletion removes an administrative notice about government funding and operating status, which does not affect trial data or the page's core purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.